Margarita is responsible business development and marketing of the Oxentia division of Oxford University Innovation and supports technology transfer projects in training, innovation policy review, and commercialisation. She joined Oxford University Innovation from Gilead Sciences in San Francisco, where she was part of the commercial operations and analytics group. She has diverse experience in international managing product launches, market research, project management, data analytics, and account management with a particular focus on HIV, HCV, and Oncology therapeutic areas. She previously worked in pharmaceutical competitive intelligence consulting in New York City and London, where she collaborated with global clients on a wide breadth of market research-based projects in manufacturing, R&D, patient support services, and commercial strategy.
Margarita has a background in computational biology, with research experience in bionanotechnology at the University of California, San Francisco and in behavioural epigenetics at Rutgers University. She completed her Master’s degree in Biotechnology and Entrepreneurship at New York University as well as her Bachelor’s degree in biomathematics at Rutgers University. In 2015, Margarita completed a project management certification (PMP) at the University of California, Berkeley.
